GLPwatch
News
Detected changes across GLP-1 drugs — label updates, shortages, recalls, and new trials, newest first, each linked to source.
2026-07-10
- Trial NCT07619508 status changed: Active not recruiting → Completed
- Trial NCT07619495 status changed: Active not recruiting → Completed
- Trial NCT07357766 status changed: Not yet recruiting → Withdrawn
- Trial NCT07417618 status changed: Active not recruiting → Completed
- Trial NCT07605052 status changed: Not yet recruiting → Active not recruiting
- Trial NCT06077864 status changed: Active not recruiting → Completed
- Trial NCT07357740 status changed: Not yet recruiting → Withdrawn
2026-06-02
- Recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceutic…
- Trial NCT06408532 status changed: Not yet recruiting → Unknown
- Trial NCT06449703 status changed: Recruiting → Unknown
- Trial NCT05646199 status changed: Not yet recruiting → Unknown
- Trial NCT06422624 status changed: Not yet recruiting → Unknown
- Trial NCT06438146 status changed: Recruiting → Unknown
2026-05-30
- Trial NCT06948422 status changed: Recruiting → Active not recruiting
- Trial NCT07194317 status changed: Enrolling by invitation → Completed
- Trial NCT07564414 status changed: Not yet recruiting → Recruiting
- Trial NCT06952530 status changed: Recruiting → Active not recruiting
- Trial NCT06948435 status changed: Recruiting → Active not recruiting